Observational Evaluation of Atopic Dermatitis in Pediatric Patients
Conditions:
Dermatitis Atopic
Sponsor: Sanofi
trial.available_in:
БГ
Overview
Primary Objectives:
* To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable.
* To evaluate the time-course of AD and selected atopic comorbidities.
Secondary Objectives:
* To characterize disease burden and unmet need.
* To describe real-world treatment patterns (eg, dosing regimens, treatment duration, and reasons for discontinuation and/or switching).
* To document the real-world effectiveness and safety of treatments.
Description
The study duration is 120 months.
Who can participate
Inclusion criteria:
* Patients with moderate to severe AD, according to the Investigator's assessment;
* Currently receiving systemic treatment (including phototherapy) for atopic dermatitis or currently on topical treatment, but otherwise candidates for systemic treatment.
Exclusion criteria:
* Concurrent participation in an interventional clinical trial which modifies patient care.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Locations
20
Argentina (1)
Investigational Site Number : 0320009
Bahía Blanca , Buenos Aires
Australia (1)
Investigational Site Number : 0360008
Kogarah , New South Wales
Brazil (1)
Universidade Federal do Paraná- Site Number : 0760003
БГ